AUEG - Single Source of Truth                 (ReactJS - POC) AUEG



AUEG


Study Title and Categorization

Study Number*
×

Auto Generating Study attributes from CTDA (API)

AUEG ID
×

Similarity AI Search - Found Identical Study (AAP)

20159664 - A Phase III Randomized Trial of Steroids+Tyrosine Kinase Inhibitor Induction with Chemotherapy or Blinatumomab for Newly Diagnosed BCR-ABL-positive Acute Lymphoblastic Leukemia in Adults

Finance Management (Geography)Global or Local Funding
Study TitleGlobal or Local Study Execution
ProductIndication

Strategy Alignment

Evidence Generation (EG) Data GapEG Data Gap, Additional Details
Evidence Generation (EG) Area of FocusEG Area of Focus, Additional Details
Intended AudienceIf External Audience, Select From List:
Intent to PublishPhysicians-Primary care

Study Design

Primary ObjectivePrimary Endpoints
Phase 0-4, Other# of Arms
Placebo Controlled?Randomized?
New Indication?# of Subjects OR Sample Size

Funding

Baseline LOS (In Local Currency)Local Currency Code
Baseline LOS (In USD)Cost of Drug Supply (USD)
Latest LOS (In Local Currency)Latest LOS (In USD)
Latest LOS – from LEIs Co-funded?
Name of Participating Party(ies)Portfolio Governance Review Required?

           
× Study Submitted Successfully !